Logo
x

Search

Subscribe Now

almirall

Almirall and Novo Nordisk Join Forces for the Development of NN-8828 to Treat Dermatological Diseases

Almirall and Novo Nordisk Join Forces for the Development of NN-8828 to Treat Dermatological Diseases

  • February 19, 2024
Insights+: EMA Marketing Authorization of New Drugs in November 2023

Insights+: EMA Marketing Authorization of New Drugs in November 2023

  • December 29, 2023
Almirall Received EC’s Approval for Ebglyss (lebrikizumab) to Treat Moderate-to-severe Atopic Dermatitis

Almirall Received EC’s Approval for Ebglyss (lebrikizumab) to Treat Moderate-to-severe Atopic Dermatitis

  • November 20, 2023
PharmaShots Weekly Snapshots (October 09–13, 2023) _

PharmaShots Weekly Snapshots (October 09–13, 2023) _

  • October 14, 2023
PharmaShots Weekly Snapshot (January 4-8, 2020)

PharmaShots Weekly Snapshot (January 4-8, 2020)

  • January 8, 2021
PharmaShots Weekly Snapshot (February 03-07, 2020)

PharmaShots Weekly Snapshot (February 03-07, 2020)

  • February 10, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.